The 7MM soft tissue sarcoma (STS) market is estimated to reach USD 6,465.7 million by 2030 from USD 2,943.3 million in 2019 at a CAGR of 7.4%.

Eldiara was diagnosed with stage 3 synovial sarcoma, a rare type of soft tissue cancer, when she was just 19 years old – and ...

The FDA has granted clearance to an investigational new drug application for CLD-201 for solid tumor treatment, based on preclinical findings.

Jane Kelly opened up about the multiple failings of doctors before her teenage daughter Megan was diagnosed with stage 4 cancer and later died of the disease.

Daraine Cunningham's primary school teacher noticed her 'swollen' left eye when she was just nine years old but GPs blamed it ...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted antitumor virotherapies, announced today that the U.S. Food and Drug ...

Eldiara was diagnosed with stage 3 synovial sarcoma, a rare type of soft tissue cancer, when she was just 19 years old – and ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced the creation of a new Sarcoma Subcommittee ...

Introduction The global Soft Tissue Sarcoma (STS) market has demonstrated significant growth potential, with projections estimating the market to grow at a Compound Annual Growth Rate (CAGR) of 7.4% ...